Navigation Links
DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference

. The day 90 median change from baseline was 6.0 and 5.0 NIHSS points in the DP-b99 and placebo groups, respectively; the day 90 median change from baseline in patients with entry NIHSS score of 10-16 was 8.0 and 5.0 points in the DP-b99 and placebo groups, respectively (p=0.03).

The trial enrolled patients within the first 9 hours following appearance of stroke symptoms. The data indicate that the effect of DP-b99 on recovery was uniform across the full 9h window, confirming the wide therapeutic window for DP-b99.

The favorable safety and tolerability profile of DP-b99 was confirmed and is in line with D-Pharm's previous clinical experience from the Phase I and IIa studies. There were no significant differences in the number or type of serious adverse events, mortality rate or death causes between the DP-b99 and placebo groups.

These results show that DP-b99 doubled the chances to recover from ischemic stroke, has at least a 9hr therapeutic window and is safe. D-Pharm is planning to commence a pivotal Phase III study of DP-b99 in 2008.

About D-Pharm Ltd.

D-Pharm (www.dpharm.com) is a biopharmaceutical company pioneering the development of lipid-like therapeutics and has generated a rich product pipeline from its drug targeting and discovery technologies, Regulated Activation of Prodrugs (D-RAPTM) and Membrane Active Chelators (MAC). The company expects to discuss the further development of DP-b99 with regulatory authorities in the coming months.

D-Pharm's pipeline includes DP-VPA, a new chemical entity that is a modified and targeted version of valproic acid for epilepsy, bipolar disorder treatment and migraine prophylaxis, currently in Phase II development. DP-460 is in preclinical development intended as an oral, disease-modifying therapy for Alzheimer's disease.

    For further information please contact:


    Tami Horovitz, PhD.

    Tel: +972-8-9385100

 
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Phase IIb Trial Results Presented the European Stroke Conference
(Date:9/2/2014)... Sept. 2, 2014 Reportlinker.com announces that ... its catalogue: Asia-Pacific Infusion Therapy ... Abstract: The ... included volumetric infusion pumps, syringe infusion pumps, disposable ... stopcocks. These categories are segmented based on the ...
(Date:9/2/2014)... -- Reportlinker.com announces that a new market research report is ... Taiwanese Markets for Minimally Invasive Spinal Devices ... market for MIS spinal devices in the ... a fast pace, albeit at different rates in different ... China , where MIS spinal fusion is ...
(Date:9/2/2014)... 2, 2014 Depomed, Inc. (Nasdaq: ... subject to market and other conditions, $230 million aggregate ... "Notes"). Depomed, Inc. ("Depomed") expects to grant the underwriters ... to an additional $34.5 million aggregate principal amount of ... Capital Markets, LLC will act as joint book-running managers ...
Breaking Medicine Technology:Asia-Pacific Infusion Therapy Device Market 2Asia-Pacific Infusion Therapy Device Market 3Asia-Pacific Infusion Therapy Device Market 4Asia-Pacific Infusion Therapy Device Market 5Asia-Pacific Infusion Therapy Device Market 6Asia-Pacific Infusion Therapy Device Market 7Asia-Pacific Infusion Therapy Device Market 8Asia-Pacific Infusion Therapy Device Market 9Asia-Pacific Infusion Therapy Device Market 10Asia-Pacific Infusion Therapy Device Market 11Asia-Pacific Infusion Therapy Device Market 12Asia-Pacific Infusion Therapy Device Market 13Asia-Pacific Infusion Therapy Device Market 14Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 2Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 3Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 4Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 5Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 6Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 7Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 8Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 9Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 2Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 3
... Oct. 9 Vical Incorporated,(Nasdaq: VICL ) ... mice demonstrated,the potential of its patented Vaxfectin(TM) adjuvant ... protein-based H5N1 pandemic influenza vaccine,currently stockpiled by the ... limited vaccine supplies to protect the greatest,number of ...
... Oct. 9 The Wellion Linus Blood Glucose,Monitoring ... recently received certification by the Netherlands Organization,for Applied ... group,founded in 1932 that thoroughly tests and inspects ... the CE Marking. "Receiving the TNO approval ...
Cached Medicine Technology:Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 2Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 3Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 4WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests 2
(Date:9/2/2014)... with early-stage breast cancer in California, the percentage undergoing ... although this procedure was not associated with a lower ... to a study in the September 3 issue of ... for the removal of one breast was associated with ... examined in the study. , Randomized trials have demonstrated ...
(Date:9/2/2014)... Dallas, TX (PRWEB) September 02, 2014 The ... proudly presenting Music4Miracles on Sept. 14th, 2014 during Spinal Cord ... Mark McKinney, Aubrey Lynn England, and Chuck Ligon. Linear Automotive ... Rod and Gasser show. , Doors open at 2pm. The ... fee which includes one free pass to the concert. There ...
(Date:9/2/2014)... Sept. 2, 2014 (HealthDay News) -- Melatonin supplements did ... hip fractures, a new study found. Many older ... delirium due to disruption of their normal sleep-wake cycle. ... factor that contributes to delirium, but there has been ... patients. This study included 378 patients, average age ...
(Date:9/2/2014)... ANGELES (Sept. 2, 2014) Measuring the levels of sex ... a sudden cardiac arrest, a heart rhythm disorder that is ... study, published online by the peer-reviewed journal Heart Rhythm ... sex hormone, were found in men who had a sudden ... hormone, were strongly associated with greater chances of having a ...
(Date:9/2/2014)... When weather conditions are right, tornadoes can ... behind a path of destruction. In fact, the United States ... 1,253 tornadoes per year. Rainbow International offers the following safety ... strikes., , Select a safe place such ... home with no windows to stay during the storm. If ...
Breaking Medicine News(10 mins):Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Gas Monkey Hosts Concert in Dallas Benefiting Dream2Walk Foundation with Linear Automotive 2Health News:Study links sex hormone levels in the blood to risk of sudden cardiac arrest 2Health News:Act Quickly in Case of Tornado: Rainbow International® Offers Tips on How to Be Prepared for a Tornado 2
... University School of Medicine (BUSM) have demonstrated that commensal ... inducers of human airway epithelial cell responses as compared ... a Neisserial outer membrane component appears to play a ... with a receptor on the surface of human airway ...
... Mozes HealthDay Reporter , MONDAY, Nov. 22 ... well-known antioxidant cousin, alpha-carotene, in fruits and vegetables can ... heart disease and cancer, new research suggests. ... -- because of the red, yellow and orange coloring ...
... Doctors at the University of Colorado School of Medicine were ... of a 64-year-old Colorado man. They extracted cells from the ... the biopsy results were inconclusive. Even a few months ... remove all or part of the thyroid. At least this ...
... become aware of the dangers of excessive fructose in diet. ... the Journal of the American Society of Nephrology ... may be. Richard J. Johnson, MD and Takahiko ... Colorado) provide a concise overview of recent clinical and experimental ...
... , MONDAY, Nov. 22 (HealthDay News) -- Increased ... United States billions of dollars a year in medical ... Medical Expenditure Panel Survey, the investigators estimated how reductions ... related conditions would affect health care spending. The ...
... Holohan HealthDay Reporter , MONDAY, Nov. 22 ... can fuel each other, a new study shows. ... subjects who were depressed had a much higher risk ... significantly higher risk of depression, compared to healthy study ...
Cached Medicine News:Health News:BUSM investigates cellular mechanisms leading to immune response in airway epithelium 2Health News:Eat Your Fruits & Veggies for Longer Life 2Health News:Eat Your Fruits & Veggies for Longer Life 3Health News:Genomic 'markers' may head off thousands of thyroid surgeries 2Health News:Disease Prevention Could Save U.S. Billions of Dollars Annually 2Health News:Diabetes, Depression Can Be Two-Way Street 2Health News:Diabetes, Depression Can Be Two-Way Street 3
Biomet® Arthrodesis Nail indications include: , Failed external fixation , Aseptic failed total knee arthroplasty , Periarticular fractures where repair is not possible , Limb salvage in tumor...
... The efficacy of treating upper ... been documented in many studies. , ... Humeral Nail System offers the benefits ... limited soft tissue dissection and early ...
... the worlds leading medical technology company ... management for more than a decade, ... Timer. The ACT Plus System is ... to determine coagulation endpoints in whole ...
... techniques have largely replaced the use of plates and ... use of rods or pins in the forearm or ... been no way to lock the pins or hold ... non-locked nail is back out of the implant. The ...
Medicine Products: